Table 3.

Multinomial logistic analysis

	RIF		Survival
	OR (CI)	p Value	OR (CI)	p Value
Control group:
Non-diabetics
Aprotinin	0.9 (0.4 to 2.2)	0.79	2.3 (0.5 to 11.2)	0.30
ACE inihibitors	1.0 (0.6 to 1.8)	0.94	0.7 (0.2 to 2.8)	0.60
Transfusion	0.9 (0.5 to 1.7)	0.79	0.8 (0.1 to 5.9)	0.69
Diabetics
Aprotinin	0.9 (0.3 to 2.8)	0.94	0.5 (0.2 to 1.4)	0.32
ACE inihibitors	1.4 (0.5 to 3.6)	0.52	12.6 (1.4 to 109.2)	0.02
Transfusion	1.6 (0.5 to 5.9)	0.4	0.7 (0.07 to 7.3)	0.77
Insulin group:
Non-diabetics
Aprotinin	0.7 (0.4 to 1.1)	0.14	2.0 (0.5 to 9.7)	0.39
ACE inihibitors	0.4 (0.3 to 0.5)	0.001	0.7 (0.2 to 3.1)	0.70
Transfusion	0.7 (0.5 to 1.1)	0.15	1.0 (0.6 to 2.9)	0.58
Diabetics
Aprotinin	1.0 (0.3 to 2.8)	0.97	1.7 (0.3 to 5.8)	0.26
ACE inihibitors	1.2 (0.7 to 2.3)	0.65	3.4 (1.2 to 12.3)	0.001
Transfusion	1.5 (0.8 to 3.0)	0.25	1.0 (0.8 to 1.1)	0.92

ACE, angiotensin-converting enzyme; CI, confidence interval; OR, odds ratio; RIF, renal failure according to RIFLE (Risk of renal failure, Injury to kidney function, Failure of kidney function, Loss of kidney function and End-stage renal failure) score criteria.